HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its pre...
Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated perso...
Moody's Ratings (Moody's) has affirmed Emerson College, MA's Baa2 issuer and revenue bond ratings. Roughly $497 million of total debt was outstanding as of June 30, 2023. The outlook is stable. RATINGS RATIONALE The affirmation of Emerson's Baa2 issuer rating reflects strong expense management...
Moody's Ratings (Moody's) said that Freedom Mortgage Holdings LLC's (Freedom) B1 corporate family rating (CFR) and B2 senior unsecured rating were unaffected by the company's decision to increase its existing senior unsecured notes due in 2029 by $300 million. Freedom's rating outlook is stable. T...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 2.2 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”). The purpose of the programme is to reduce the company’s share capital and to meet o...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S’ 2024 share repurchase programme of up to a total of DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. The transaction price is DKK 860.02 per share and has been calculated as the three-day volume we...
Moody's Ratings (Moody's) has assigned definitive ratings to twelve classes of CMBS securities, issued by BANK5 Trust 2024-5YR6, Commercial Mortgage Pass-Through Certificates, Series 2024-5YR6: Cl. A-1, Definitive Rating Assigned Aaa (sf) Cl. A-3, Definitive Rating Assigned Aaa (sf) Cl. A-3-1, D...
Moody's Ratings (Moody's) has assigned provisional ratings to one class of notes to be issued and one class of loans to be incurred by Generate CLO 15 Ltd (the "Issuer" or "Generate 15"). Moody's rating action is as follows: U.S.$238,000,000 Class A Floating Rate Notes due 2037, Assigned (P)Aaa ...
PARIS--(BUSINESS WIRE)-- Regulatory News: Clariane (Paris:CLARI) (CLARIA.PA – ISIN FR0010386334) : le Groupe annonce aujourd’hui avoir reçu une promesse d’achat de la part de la Fondation Santé Service et consenti une exclusivité en vue de la cession de l’ensemble de ses activités d’Hospitalisation à Domicile et Services de Soins Infirmiers à Domicile (HAD/SSIAD) en France. Cet accord intervient à l'issue d'un processus d'appel d'offres auquel ont participé plusieurs acteurs du secteur. Reconnue d'utilité publique depuis 2013, La Fondation Santé Service est le premier acteur français de l'...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.